Health Care Technology

MGT Capital Investments, Inc. (NYSE: MGT), today announced that on June 8, 2011 it received notice from the NYSE Amex notifying the Company it is not in compliance with following Exchange continued listing standards: Section 1003(a)(i) of the Company Guide, resulting from stockholders' equity...

Stifel Nicolaus has upgraded Omnicell (NASDAQ: OMCL) from Hold to Buy and has established a $17 price target.

Piper Jaffray is out with its report today on Omnicell (NASDAQ: OMCL), reiterating Overweight. In a note to clients, Piper Jaffray writes, "We believe companies that invest during downturns do better on the recovery, and that OMCL is set up for a strong recovery after investing heavily in new...

Cusick's Corner Let's take a look at a major sector -- most notably beaten up is Energy, Crude down $-2.19, and the Energy ETF XLE has broken support. This break is a potential signal that the part of the market that has been outperforming is now under pressure since the Saudis came in and upped...

Cusick's Corner Lately I have had a new mantra, "Be an Optimist." However, there is not much on the financial landscape that makes me feel that way, nothing. But I remind myself that emotion is the very thing trading is all about. There are strategies that play to this very mood, .i.e. bearish...

Here are today's Put/Call Ratio leaders… 1. Federated Investors (NYSE: FII) 3,829 puts, 60 calls 2. Yum Brands (NYSE: YUM) 14,110 puts, 230 calls 3. Novagold Resources (NYSE: NG) 75,976 puts, 1,530 calls 4. Ann Inc. (NYSE: ANN) 4,008 puts, 84 calls 5. Allscripts Healthcare Solutions (NASDAQ: MDRX...

Shares of Allscripts Healthcare Solutions (NASDAQ: MDRX) are lower on the session by 2.86%, trading at $18.65. Overall put volume is now running at 25.32x the daily average, with 91% of all puts traded being purchases on the offer. 2,608 contracts have traded on the session so far. Allscripts...

Merge Healthcare (NASDAQ: MRGE) and Ophthalmic Imaging Systems (OTC: OISI) today announced the signing of a definitive merger agreement pursuant to which Merge Healthcare will acquire OIS. Under the terms of the definitive merger agreement, OIS shareholders will receive 0.1693 share of Merge...

Yesterday afternoon, Cerner (NASDAQ: CERN) announced that its Board of Directors has authorized a 2-for-1 share split, Deutsche Bank reports. “The date of record is June 15, and the share split becomes effective on June 24,” Deutsche Bank writes. “Cerner currently has ~84.4 million shares...

According to Auriga, Omnicell (NASDAQ: OMCL) Buy rating is reiterated. Auriga said that it is reiterating its BUY rating on Omnicell (OMCL) after a day of investor meetings last week. “The company occupies a solid #2 position (23% market share) behind market leader Carefusion (CFN, NR) and...

According to Oppenheimer, MedAssets (NASDAQ: MDAS) announced that its agreement with the Texas Purchasing Coalition has been amended to include Hendrick Health System. Oppenheimer said that normally, it would not comment on the inclusion of an additional hospital to a GPO contract. “However, given...

MedAssets (NASDAQ: MDAS) today announced it has amended its multi-year agreement with Texas Purchasing Coalition to provide for the addition of its newest member, Hendrick Health System, which includes a 504-bed acute care medical center located in Abilene, Texas. The amendment follows the...

According to Piper Jaffray, MedAssets (NASDAQ: MDAS) price target is lowered. Piper Jaffray said that has announced the resignation of Pat Ryan, President of the Spend Management Division, Board Member, and former CEO of Broadlane. “On the one hand, this is not new news because management hinted as...

Piper Jaffray has lowered the price target on MedAssets (NASDAQ: MDAS) from $15 to $11 and maintains its Underweight rating.

Citi reiterated its Buy rating on Cerner Corporation (NASDAQ: CERN). At the same time, Citi increased its price target on the company's stock from $117 to $152. In a research report published today, Citi cited increasing healthcare IT spending as the reason for its decision. In the report, Citi...